DNA X, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from DNA X, Inc.'s yearly results (2022–2025), compared with Financial Services companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Self-Funding Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Cash Locked Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Less steady than 71% of Financial Services companies in United States.
Growth Efficiency Ratio
—Sales fell 100%
Sales fell 100% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-100% / -18%In 3 years sales changed by -100% while total assets changed by -18%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Cash Cushion Ratio
—Not applicable for banks
Deposits and loans are a bank's raw material, so cash-flow and debt figures mean something different for banks.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (7)
DNA X, Inc. made a loss over the last year. DNA X, Inc. owes $1.27 for every $1 it owns. DNA X, Inc. made a loss in each of the last two years.
Compared with Financial Services companies in United States · latest annual results Dec 2025.
P/E ratio
LossDNA X, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-3.85DNA X, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$5 MThe total market value of all of DNA X, Inc.'s shares at today's price (share price × number of shares), smaller than almost all Financial Services companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeDNA X, Inc.'s net worth is negative ($1 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.27×DNA X, Inc. owes $1.27 for every $1 it owns, so it owes more than it owns, higher than almost all Financial Services companies in United States. Banks and lenders usually show higher figures.
Dividend yield
NoneDNA X, Inc. does not currently pay a dividend.
Profit growth
LossDNA X, Inc. made a loss in each of the last two years.
Questions
How much does DNA X, Inc. owe compared with what it owns?
DNA X, Inc. owes $1.27 for every $1 it owns, so it owes more than it owns, higher than almost all Financial Services companies in United States. Banks and lenders usually show higher figures.
Does DNA X, Inc. pay a dividend?
No. DNA X, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.